Cabaletta Bio earnings were -$126.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CABA earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$35.9M, up 10.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CABA reported annual earnings of -$115.9M, with 71.2% growth.
On CABA's earnings call on Invalid Date, Cabaletta Bio (NASDAQ: CABA) reported Q1 2025 earnings per share (EPS) of -$0.71, up 39.22% year over year. Total CABA earnings for the quarter were -$35.94 million. In the same quarter last year, Cabaletta Bio's earnings per share (EPS) was -$0.51.
As of the last Cabaletta Bio earnings report, Cabaletta Bio is currently losing money. Cabaletta Bio's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$126.76 million, a 64.91% increase year over year.
What was CABA's earnings growth in the past year?
As of Cabaletta Bio's earnings date in Invalid Date, Cabaletta Bio's earnings has grown year over year. CABA earnings in the past year totalled -$126.76 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.